ROLE OF P65 AND P53 EXPRESSION IN DIFFERENT STAGE AND GRADE OF OVARIAN CANCER

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Indian journal of applied research

• Publication date

  2018-02-10

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer

  2015cited by this paper
• A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer

  2014cited by this paper
• Role of NF-κB as a Prognostic Marker in Breast Cancer : A Pilot Study in Indian Patients

  2013cited by this paper
• Role of nuclear factor-κB in female breast cancer: a study in Indian patients.

  2012cited by this paper
• Prognostic significance of HER-2/neu and survival of breast cancer patients attending a specialized breast clinic in Kolkata, Eastern India.

  2012cited by this paper
• The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer

  2011cited by this paper
• Inhibiting NF-κB activation by small molecules as a therapeutic strategy.

  2010cited by this paper
• Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancer

  2010cited by this paper
• Potential pharmacological control of the NF-κB pathway.

  2009cited by this paper
• Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.

  2009cited by this paper
• Study of 'patterns of care' of ovarian cancer patients in a specialized cancer institute in Kolkata, eastern India.

  2009cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Biological characterization of ovarian cancer: prognostic and therapeutic implications.

  2005cited by this paper
• The NF-κB/IκB signaling system: A molecular target in breast cancer therapy

  2005cited by this paper
• The IKK/NF-κB activation pathway—a target for prevention and treatment of cancer

  2004cited by this paper
• Shaping the nuclear action of NF-kappaB.

  2004cited by this paper
• Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.

  2004cited by this paper
• Nuclear Factor-κB Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer

  2004cited by this paper
• NF-κB in cancer—a friend turned foe

  2004cited by this paper
• p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1

  2003cited by this paper
• p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.

  2002cited by this paper
• p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53.

  2000cited by this paper
• Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

  1994cited by this paper

• No citing papers are available for this paper.